ArticleCirculation. Heart failure2022

Response by Elliott et al to Letter Regarding Article, "Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy".

Perry Elliott et al.PubMed ↗Publisher ↗

No numbers read from the abstract.